L’avis intitulé « Vaccin antigrippal FLUCELVAX : transition du vaccin antigrippal FLUCELVAX, de sa forme quadrivalente à une forme trivalente, dans la stratégie de vaccination contre la grippe saisonnière », ci-joint, est adopté.
Voir aussi
Recommandation vaccinale
13/02/2025
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
A9VnF91Lkz6tTBpg
